Coventry University Featured PhD Programmes
Loughborough University Featured PhD Programmes
University of Reading Featured PhD Programmes

Cancer: Epigenetic therapy using ultrasound-mediated microbubble drug delivery for cancer treatment


   Faculty of Medicine and Health


Leeds United Kingdom Bioinformatics Biomedical Engineering Biophysics Cancer Biology Cell Biology Medical Physics Molecular Biology Radiology

About the Project

The project is an interdisciplinary, pre-clinical study that aims to investigate the response of human tumour cells to treatment with epigenetic inhibitors (such as DNA methyltransferase inhibitors), as a potential combination therapy for colorectal cancer (CRC). As epigenetic modifications contribute to tumour growth, drugs that modify the epigenome have great potential for cancer therapy. Epigenetic drugs have the capability to target cancer stem cells, restore sensitivity of tumour cells to chemotherapy or to prime tumours prior to secondary treatment with immune checkpoint inhibitors.

Tumour cell lines will be tested for response to combination drug treatments using 2D/3D cell culture and other models. Microbubbles will be generated using the University of Leeds patented microfluidic system, and could be combined with liposomes containing encapsulated drugs. Novel cancer models or therapeutic microbubbles could be developed further for targeted drug delivery. Our long-term aim is for ultrasound-triggered microbubble delivery to deliver drugs more efficiently to tumours, to enhance therapeutic response and to minimize off-target side effects.

You will work closely with members of other groups at the University of Leeds including Professor Evans’ group in the School of Physics and Astronomy. The project will involve training in a wide variety of techniques and research skills. These may include mammalian cell culture, drug testing using monolayer or spheroid/organoid cell culture, molecular biology and cell biology techniques to monitor epigenetic biomarkers of response, generation and testing of functional microbubbles in cancer models and drug delivery using ultrasound.

You will be trained as part of an established, interdisciplinary team of clinicians, academics and research scientists- the Leeds Microbubble Consortium- that includes PhD researchers from other Schools in the University.

This project is part of the International PhD Academy: Medical Research

Eligibility:

You should hold a first degree equivalent to at least a UK upper second class honours degree in a relevant subject.

Candidates whose first language is not English must provide evidence that their English language is sufficient to meet the specific demands of their study. The Faculty of Medicine and Health minimum requirements are:

  • British Council IELTS - score of 7.0 overall, with no element less than 6.5
  • TOEFL iBT - overall score of 100 with the listening and reading element no less than 22, writing element no less than 23 and the speaking element no less than 24.

How to apply:

Applications can be made at any time. To apply for this project applicants should complete an online application form and submit this alongside a full academic CV, degree transcripts (or marks so far if still studying) and degree certificates. Please make it clear in the research information section that you are applying for the International PhD Academy: Medical Research, as well as the title of the project you wish to be considered for.

We also require 2 academic references to support your application. Please ask your referees to send these references on your behalf, directly to

Any queries regarding the application process should be directed to


Funding Notes

This project is aimed at International applicants who are able to self fund their studies or who have a sponsor who will provide their funding.

Email Now


Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.